secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2024-03-04T23:59:59+00:00
Accession:  0001493152-24-008720
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical appoints Jolie Kahn as CFO effective March 1; predecessor Kalra resigned Jan 30
--------------------------------------------------------------------------------

- Gurinder Kalra resigned as CFO effective January 30, 2024 to pursue other interests.
- Jolie Kahn was confirmed as CFO on March 1, 2024; she also serves as legal counsel to the company.
- Kahn has corporate finance and securities law background; prior CFO roles at GlucoTrack (2019-2023) and interim CFO at ToughBuilt.
- Compensation: $22,500 per month for CFO and counsel services.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224008720/0001493152-24-008720-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315224008720/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-008720

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer